Just as an adjunct to my previous post. I have been playing with Ai Chat to work out a price BP may consider paying.
I suggested gross revenue of $6 billion [US] using Relyvrio as an example. I suggested a net profit of 1.2 billion a year. [Which seems to be the norm from what I have read] I did not include ODD or patent protection until 2033, deciding to keep it simple. Nor did i suggest Monepantel should eclipse the uptake of Relyvrio and that Relyvrio had a 43% drop out rate due to side effects, or that patients may be on Monepantel for longer periods, thus increasing uptake/sales.
The suggested value that a BP may consider is around $2.5 Billion US. Or $3.7 billion AUD.
I probably have 2 much time on my hands. And am in no way an accountant, so don't hold me to it.
Cheers
- Forums
- ASX - By Stock
- Share Purchase Plan (SPP)
Just as an adjunct to my previous post. I have been playing with...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAA (ASX) to my watchlist
|
|||||
Last
19.0¢ |
Change
0.005(2.70%) |
Mkt cap ! $92.38M |
Open | High | Low | Value | Volume |
19.0¢ | 19.5¢ | 18.5¢ | $382.4K | 2.009M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 178766 | 18.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
19.0¢ | 361999 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 178766 | 0.185 |
7 | 148281 | 0.180 |
4 | 290677 | 0.175 |
7 | 495800 | 0.170 |
4 | 385807 | 0.165 |
Price($) | Vol. | No. |
---|---|---|
0.190 | 361999 | 2 |
0.195 | 365684 | 6 |
0.200 | 419009 | 13 |
0.205 | 221875 | 2 |
0.215 | 20625 | 2 |
Last trade - 16.10pm 02/09/2024 (20 minute delay) ? |
Featured News
PAA (ASX) Chart |